BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 27623929)

  • 1. Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα.
    Karwad MA; Macpherson T; Wang B; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE
    FASEB J; 2017 Feb; 31(2):469-481. PubMed ID: 27623929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB
    Karwad MA; Couch DG; Wright KL; Tufarelli C; Larvin M; Lund J; O'Sullivan SE
    Biochem Pharmacol; 2019 Oct; 168():465-472. PubMed ID: 31325449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CB
    Karwad MA; Couch DG; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE
    FASEB J; 2017 Aug; 31(8):3267-3277. PubMed ID: 28404744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.
    Borrelli F; Romano B; Petrosino S; Pagano E; Capasso R; Coppola D; Battista G; Orlando P; Di Marzo V; Izzo AA
    Br J Pharmacol; 2015 Jan; 172(1):142-58. PubMed ID: 25205418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability.
    Alhamoruni A; Lee AC; Wright KL; Larvin M; O'Sullivan SE
    J Pharmacol Exp Ther; 2010 Oct; 335(1):92-102. PubMed ID: 20592049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Oleoylethanolamine Reduces Inflammatory Cytokines and Adhesion Molecules in TNF-α-induced Human Umbilical Vein Endothelial Cells by Activating CB2 and PPAR-α.
    Xu X; Guo H; Jing Z; Yang L; Chen C; Peng L; Wang X; Yan L; Ye R; Jin X; Wang Y
    J Cardiovasc Pharmacol; 2016 Oct; 68(4):280-291. PubMed ID: 27281236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance.
    Borrelli F; Izzo AA
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):33-49. PubMed ID: 19285259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.
    Couch DG; Cook H; Ortori C; Barrett D; Lund JN; O'Sullivan SE
    Inflamm Bowel Dis; 2019 May; 25(6):1006-1018. PubMed ID: 31054246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice.
    Cluny NL; Keenan CM; Lutz B; Piomelli D; Sharkey KA
    Neurogastroenterol Motil; 2009 Apr; 21(4):420-9. PubMed ID: 19140957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide.
    Ambrosino P; Soldovieri MV; Russo C; Taglialatela M
    Br J Pharmacol; 2013 Mar; 168(6):1430-44. PubMed ID: 23083124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors.
    Ho WS; Barrett DA; Randall MD
    Br J Pharmacol; 2008 Nov; 155(6):837-46. PubMed ID: 18695637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis.
    Sanchez AM; Cioffi R; Viganò P; Candiani M; Verde R; Piscitelli F; Di Marzo V; Garavaglia E; Panina-Bordignon P
    Reprod Sci; 2016 Aug; 23(8):1071-9. PubMed ID: 26887427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal and fasting/refeeding-regulated tissue levels of endogenous PPAR-alpha ligands in Zucker rats.
    Izzo AA; Piscitelli F; Capasso R; Marini P; Cristino L; Petrosino S; Di Marzo V
    Obesity (Silver Spring); 2010 Jan; 18(1):55-62. PubMed ID: 19521349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.
    Capasso R; Orlando P; Pagano E; Aveta T; Buono L; Borrelli F; Di Marzo V; Izzo AA
    Br J Pharmacol; 2014 Sep; 171(17):4026-37. PubMed ID: 24818658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oleoylethanolamide and Palmitoylethanolamide Enhance IFNβ-Induced Apoptosis in Human Neuroblastoma SH-SY5Y Cells.
    Camoglio C; Balla J; Fadda P; Dedoni S
    Molecules; 2024 Apr; 29(7):. PubMed ID: 38611871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of transient receptor potential vanilloid receptor 1 and peroxisome proliferator-activated receptors-α in mediating the antinociceptive effects of palmitoylethanolamine in rats.
    Aldossary SA; Alsalem M; Kalbouneh H; Haddad M; Azab B; Al-Shboul O; Mustafa AG; Obiedat S; El-Salem K
    Neuroreport; 2019 Jan; 30(1):32-37. PubMed ID: 30418420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy.
    Citraro R; Russo E; Scicchitano F; van Rijn CM; Cosco D; Avagliano C; Russo R; D'Agostino G; Petrosino S; Guida F; Gatta L; van Luijtelaar G; Maione S; Di Marzo V; Calignano A; De Sarro G
    Neuropharmacology; 2013 Jun; 69():115-26. PubMed ID: 23206503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon.
    Couch DG; Tasker C; Theophilidou E; Lund JN; O'Sullivan SE
    Clin Sci (Lond); 2017 Nov; 131(21):2611-2626. PubMed ID: 28954820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia.
    Holubiec MI; Romero JI; Suárez J; Portavella M; Fernández-Espejo E; Blanco E; Galeano P; de Fonseca FR
    Psychopharmacology (Berl); 2018 Oct; 235(10):2929-2945. PubMed ID: 30058012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARα) and its lipid ligands.
    Fidaleo M; Fanelli F; Ceru MP; Moreno S
    Curr Med Chem; 2014; 21(24):2803-21. PubMed ID: 24606520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.